Niagen Bioscience, Inc. - Director's Dealing 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2023-08-12

Reporting Person: Gerber Brianna (Chief Financial Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-12	Common Stock	M	22436	—	Acquired	22436	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-12	Restricted Stock Unit	$	M	22436	Disposed		Common Stock (22436)	Direct

Security	Shares	Ownership
Common Stock	1238	Indirect

F1: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Person.

F2: On August 12, 2022, the Reporting Person was awarded RSUs which will be settled in shares of Common Stock when vested.

F3: 1,238 shares held by Jacob Gerber who is a spouse of Brianna Gerber.

F4: RSUs shall vest and be settled in shares of Common Stock in three substantially equal annual installments beginning on August 12, 2023.